[Use of glucomannan dietary fiber in changes in intestinal habit].

G.E.N Pub Date : 1995-01-01
L J Marsicano, M L Berrizbeitia, A Mondelo
{"title":"[Use of glucomannan dietary fiber in changes in intestinal habit].","authors":"L J Marsicano,&nbsp;M L Berrizbeitia,&nbsp;A Mondelo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>It has been proven that fiber is effective in the treatment of multiple nosological entities, specially of the colonic pathology. In the present study, two dose of Glucomannan (3 gr/day and 4 gr/day) were evaluated within the modification of the intestinal habit and stool characteristics. 60 patients were included in a random, parallel, double blind, cross over trial study versus placebo. The modification of the intestinal habit was evaluated through variations of daily and weekly evacuations, appraising the stool's consistency and size, satiety after meals tiresomeness between meals, constipation, diarrhea and flatulence. An increase in the number of daily and weekly evacuations during the Glucomannan vs placebo treatment was appreciated and, between the two dose of Glucomannan, a difference was observed as to the large the dose, the large the number of daily and weekly evacuations. Evacuations during the phase of Glucomannan 3 gr/day increased 0.5 times per day, 3 more per week above baseline values. On the 4 gr/day treatment of Glucomannan evacuations increased 0.9 times per day, 6 more per week above baseline values. Patient during the placebo period presented no statistically significant different. No difference was appreciated as to post-meal satiety, nor tiresomeness between meals, possibly due to treatment periods being 5 weeks long. No larger number of cases with diarrhea or flatulence were appreciated with the use of Glucomannan. Glucomannan proved to be superior to placebo, and the 3 gr/day and 4 gr/day doses turned out to beneficial in the improvement of the assessed parameters--better results were obtained using 4 gr/day of Glucomannan than 3 gr/day.</p>","PeriodicalId":75872,"journal":{"name":"G.E.N","volume":"49 1","pages":"7-14"},"PeriodicalIF":0.0000,"publicationDate":"1995-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"G.E.N","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

It has been proven that fiber is effective in the treatment of multiple nosological entities, specially of the colonic pathology. In the present study, two dose of Glucomannan (3 gr/day and 4 gr/day) were evaluated within the modification of the intestinal habit and stool characteristics. 60 patients were included in a random, parallel, double blind, cross over trial study versus placebo. The modification of the intestinal habit was evaluated through variations of daily and weekly evacuations, appraising the stool's consistency and size, satiety after meals tiresomeness between meals, constipation, diarrhea and flatulence. An increase in the number of daily and weekly evacuations during the Glucomannan vs placebo treatment was appreciated and, between the two dose of Glucomannan, a difference was observed as to the large the dose, the large the number of daily and weekly evacuations. Evacuations during the phase of Glucomannan 3 gr/day increased 0.5 times per day, 3 more per week above baseline values. On the 4 gr/day treatment of Glucomannan evacuations increased 0.9 times per day, 6 more per week above baseline values. Patient during the placebo period presented no statistically significant different. No difference was appreciated as to post-meal satiety, nor tiresomeness between meals, possibly due to treatment periods being 5 weeks long. No larger number of cases with diarrhea or flatulence were appreciated with the use of Glucomannan. Glucomannan proved to be superior to placebo, and the 3 gr/day and 4 gr/day doses turned out to beneficial in the improvement of the assessed parameters--better results were obtained using 4 gr/day of Glucomannan than 3 gr/day.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[使用葡甘露聚糖膳食纤维改变肠道习惯]。
事实证明,纤维对多种疾病的治疗是有效的,特别是结肠病理。在本研究中,评估了两种剂量的葡甘露聚糖(3克/天和4克/天)对肠道习惯和粪便特征的改变。60名患者被纳入一项随机、平行、双盲、交叉试验研究,与安慰剂对照。肠道习惯的改变通过每日和每周排便的变化来评估,评估大便的稠度和大小,饭后饱腹感,两餐之间的疲倦感,便秘,腹泻和胀气。在葡甘露聚糖与安慰剂治疗期间,每日和每周排出的数量有所增加,并且在两种剂量的葡甘露聚糖之间,观察到剂量越大,每日和每周排出的数量越大。在葡甘露聚糖3克/天的排泄阶段,每天增加0.5倍,每周比基线值多3次。在4克/天的治疗中,葡萄糖甘露聚糖的排出量每天增加0.9倍,每周比基线值多6倍。患者在安慰剂期无统计学差异。餐后饱腹感和两餐之间的疲倦感没有差异,这可能是由于治疗时间长达5周。使用葡甘露聚糖后,腹泻或肠胃胀气的病例没有增加。葡甘露聚糖被证明优于安慰剂,3克/天和4克/天的剂量在改善评估参数方面是有益的——4克/天的葡甘露聚糖比3克/天的效果更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Hepatitis C virus]. [Evaluation of methods for the diagnosis of Helicobacter pylori infection]. [Leptospirosis in Gastroenterology. Study of 14 cases in the Hospital Universitário de Caracas 1984-1994]. [Gastrointestinal stromal sarcoma. Report of a case and review of the literature]. [Von Recklinghausen disease and hepatic neurofibromatosis].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1